STING1 and neoplasm: TREX2 degrades cytosolic DNA, repressing cGAS-STING activation, leading to less apoptosis of tumor cells and downregulated CD8+ T cell infiltration in the TME, ultimately enhancing resistance to immunoblockade therapy [17].